Today: 6 November 2025
Subscribe
Browse Category

Business News News 6 October 2025 - 12 October 2025

Tariff Shock: Iconic 169-Year-Old Orvis Slashes 36 Stores

Tariff Shock: Iconic 169-Year-Old Orvis Slashes 36 Stores

Orvis’s announcement on Oct. 10, 2025 took many by surprise. The Boston Globe and Fox Business report that Orvis – one of America’s oldest outfitters – will shutter 36 stores by early 2026 bostonglobe.com retaildive.com. In a statement, Orvis President Simon Perkins explained that “changes in US trade policy had … caused a sizable shift” in the company’s model bostonglobe.com. He said the firm must “rescale the business by tightening our assortment and reducing our corporate store footprint” to ensure “a durable brand and model for decades to come” bostonglobe.com fox10phoenix.com. As Perkins put it, Orvis is “returning to our
12 October 2025
 ·  ·  ·  ·  ·  ·  ·  ·  · 
Mexican Dining Crisis: Beloved Chains File Bankruptcy and Close Doors as Industry Hits Breaking Point

Mexican Dining Crisis: Beloved Chains File Bankruptcy and Close Doors as Industry Hits Breaking Point

In summary, a squeeze on mid-tier Mexican chains is underway: beloved sit-down restaurants are shuttering locations or reorganizing under bankruptcy, even as fast-casual Mexican concepts (like Chipotle) remain popular. Oversupply of similar full-service concepts, plus inflation and labor costs, have forced chains like Abuelo’s to downsize dramatically ibtimes.co.uk calcoasttimes.com. Experts say the fallout is a wake-up call – legacy diners must adapt or consolidate. On the bright side, overall demand for dining out is not collapsing (Sysco reports only a ~1% dip in traffic industry-wide ts2.tech), and consumer surveys show that most people still enjoy eating at restaurants restaurant.org. If
12 October 2025
 ·  ·  ·  · 
AstraZeneca (AZN) Stock Skyrockets: $50B U.S. Gamble, Trump Pricing Deal & Analyst Forecasts

AstraZeneca (AZN) Stock Skyrockets: $50B U.S. Gamble, Trump Pricing Deal & Analyst Forecasts

Company Background AstraZeneca PLC is a leading Anglo-Swedish pharmaceutical giant specializing in oncology, respiratory, cardiovascular/metabolic, and rare disease medicines marketbeat.com astrazeneca.com. Headquartered in Cambridge, UK, it maintains primary listings on the London Stock Exchange and Nasdaq Stockholm, with secondary ADR trading in the U.S. astrazeneca.com. The company was formed in 1999 by merging Sweden’s Astra AB and the UK’s Zeneca. Its 2024 revenues were $54.07 billion astrazeneca.com, driven by top-selling drugs like Tagrisso (lung cancer), Lynparza (ovarian cancer), Farxiga (diabetes), and Symbicort (asthma) marketbeat.com. In its 2024 Annual Report, AZN describes itself as “a global, science-led, patient-focused pharmaceutical business” and targets
11 October 2025
 ·  ·  ·  · 
Ebius Group N.V. (Nasdaq: NBIS) Stock Skyrockets on $17B AI Deal – What Investors Must Know

Ebius Group N.V. (Nasdaq: NBIS) Stock Skyrockets on $17B AI Deal – What Investors Must Know

Company Overview Ebius Group N.V. (Nasdaq: NBIS), commonly known as Nebius, is a high-growth AI cloud infrastructure company. It was spun out of Yandex N.V. in mid-2024 when the Russian internet giant’s overseas assets were split off; Arkady Volozh (Yandex founder) remains CEO ts2.tech. Headquartered in Amsterdam, Nebius builds and operates GPU-powered data centers and a full-stack AI cloud. Its platform includes NVIDIA GPUs (H100/H200 and next-gen GB300 chips), software tools, storage and managed services (Kubernetes, databases, ML pipelines) tailored for AI development reuters.com ts2.tech. Nebius’s stated goal is to be a “neo-cloud” provider, differentiating by offering fully-managed AI compute
10 October 2025
 ·  ·  ·  ·  · 
IREN Stock Skyrockets 500% as Bitcoin Miner Reinvents Itself as AI Cloud Powerhouse

IREN Stock Skyrockets 500% as Bitcoin Miner Reinvents Itself as AI Cloud Powerhouse

Business Model & Industry IREN began as Iris Energy, a clean-energy Bitcoin miner, and has pivoted sharply into data centers for AI/HPC workloads. Its model is vertically integrated: it owns land, power contracts, and facilities (Canada, Texas) all run on 100% renewable hydro and wind power ts2.tech. This “green” setup gave IREN some of the lowest mining costs in the industry (around $0.03–$0.038 per kWh) ts2.tech ts2.tech. By mid-2024 it had ~20 EH/s of hashpower, making it a top-tier miner. Starting in 2024, management began aggressively re-purposing idle capacity to AI computing ts2.tech. In August 2025 it became an Nvidia “Preferred
10 October 2025
 ·  ·  ·  ·  · 
Delta’s Profits Take Off as Travel Demand Soars – Airline Signals Record Holiday Season Ahead

Delta’s Profits Take Off as Travel Demand Soars – Airline Signals Record Holiday Season Ahead

Delta Delivers Soaring Q3 Results Delta Air Lines kicked off airline earnings season with a strong September-quarter performance that blew past projections. The carrier earned $1.42 billion in net income for Q3 2025 – almost 60% higher than the year-ago period – translating to $2.17 per share (GAAP) marketscreener.com. Excluding one-time items, Delta’s profit was $1.71 per share, comfortably above the ~$1.52 analysts expected marketscreener.com. Revenue for the quarter reached $16.67 billion, beating forecasts (~$15.8 billion) and marking a ~8% increase year-on-year marketscreener.com. These results came in at the top end of management’s guidance, as Delta benefited from robust travel demand over the
9 October 2025
 ·  ·  ·  ·  · 
MedTech Giant’s IPO Shakes Up Market: Ottobock’s Blockbuster Debut Revives IPO Hopes

MedTech Giant’s IPO Shakes Up Market: Ottobock’s Blockbuster Debut Revives IPO Hopes

Ottobock’s Blockbuster Debut in Frankfurt Ottobock’s IPO made headlines as the prosthetics manufacturer delivered a much-needed jolt to Germany’s capital market. Trading in Ottobock shares began on October 9, 2025, on the Frankfurt Stock Exchange’s Prime Standard segment. The stock’s first trade at €72.00 was significantly above the €66 per share offering price deutsche-boerse.com. That opening price equated to about a +9% “pop” for IPO investors, underscoring the high demand for the shares. In fact, Ottobock’s debut is being celebrated as “the country’s largest IPO in over a year”, according to Reuters globalbankingandfinance.com. It’s a standout given the recent scarcity of large offerings in Frankfurt. The initial
9 October 2025
 ·  ·  ·  · 
OpenAI’s Mega-Deals with Nvidia & AMD Spark a $1 Trillion AI Frenzy

OpenAI’s Mega-Deals with Nvidia & AMD Spark a $1 Trillion AI Frenzy

OpenAI Fuels a $1 Trillion AI Hardware Boom OpenAI – the creator of ChatGPT – has positioned itself at the center of an AI hardware buying frenzy that is reshaping the tech industry. In the past few weeks (early October 2025), OpenAI announced two blockbuster chip-supply deals that together span 16 gigawatts of computing capacity – an almost inconceivable scale. (For perspective, 16 GW of data center power is roughly equivalent to the output of 16 large power plants.) These deals, one with long-time AI chip leader Nvidia and the other with rival AMD, are helping propel what analysts dub a “trillion-dollar
8 October 2025
 ·  ·  ·  · 
Cobalt Blue’s Stock Skyrockets Amid Cobalt Comeback – Broken Hill Deal, Refinery Plans Fuel Hype

Cobalt Blue’s Stock Skyrockets Amid Cobalt Comeback – Broken Hill Deal, Refinery Plans Fuel Hype

Recent News: Stock Surge & Milestones Cobalt Blue’s stock made headlines in early October 2025 after a breathtaking spike. On October 6 alone, shares rocketed nearly 50% higher to A$0.13 intelligentinvestor.com.au, extending a weeklong rally that saw the price more than double. By October 7, the stock hit an intraday high of $0.155 before settling at $0.115 intelligentinvestor.com.au – still up ~18% for the day and over 100% for the week. This sudden surge came on the heels of major news: the company announced it had fully paid off a promissory note owed to American Rare Earths, thus finalizing its
7 October 2025
 ·  ·  ·  · 
Comerica’s Mega Merger Shock: Why CMA Stock Skyrocketed as Fifth Third’s $10.9 Billion Deal Reshaped Regional Banking

Fifth Third’s $10.9 B Comerica Takeover Shakes Up Banking – Will Comerica Park Get a New Name?

A $10.9 B Deal to Create a Top-10 Bank Fifth Third Bancorp, based in Cincinnati, agreed to acquire Comerica Inc. of Dallas in an all-stock transaction valued at $10.9 billion reuters.com. The merger will form the nation’s ninth-largest bank by assets, a financial giant with approximately $288 billion in total assets and a deep footprint across multiple regions reuters.com ts2.tech. Under the deal terms announced October 6, each Comerica share will be exchanged for 1.8663 shares of Fifth Third stock ir.53.com. At Fifth Third’s pre-announcement share price, that equates to $82.88 per Comerica share, representing about a 20% premium over Comerica’s recent average
6 October 2025
 ·  ·  ·  ·  ·  · 
Broadcom’s $10B AI Chip Deal Ignites Stock Surge – What’s Powering This Tech Giant’s Boom

Broadcom’s $10B AI Chip Deal Ignites Stock Surge – What’s Powering This Tech Giant’s Boom

OpenAI’s pursuit of custom AI hardware has led it to Broadcom for chip design collaboration, aiming to reduce reliance on Nvidia. Broadcom’s CEO confirmed a huge $10 billion order from a new cloud client (believed to be OpenAI), catalyzing investor excitement ts2.tech nasdaq.com. Broadcom’s Financial Surge Amid the AI Gold Rush Broadcom is riding a wave of unprecedented demand for AI infrastructure, translating into stellar financial results. In its Q3 FY2025 earnings, Broadcom reported record revenue of $16.0 billion, a +22% YoY jump, handily beating estimates ts2.tech. Net income and cash flows are robust – free cash flow hit $7.0 billion in the
6 October 2025
 ·  ·  ·  ·  · 
Pfizer Stock 2025: 7% Dividend, Obesity Gamble, and Wall Street’s Verdict

Pfizer Stock Soars After Trump’s Drug Deal and Obesity Bet – Is This the Start of a Comeback?

Stock Performance: From Laggard to Late-September Lift For much of 2025, Pfizer’s stock was stuck in a rut – but that changed dramatically as Q4 approached. By late September, PFE had drifted down near multi-year lows around $23, reflecting a post-pandemic hangover. As of Sept 25, the stock was down roughly 9% year-to-date and about 18% below its level one year prior ts2.tech. It traded near the bottom of its 52-week range ($20.92 – $30.43), weighed down by steep declines in COVID vaccine and pill sales and general pessimism on its growth prospects ts2.tech ts2.tech. In fact, Pfizer’s COVID-driven revenues
6 October 2025
 ·  ·  ·  ·  ·  ·  · 
1 … 10 11 12 13 14 … 16
Go toTop